The Role of Altered Nutrient Partitioning in Food Reward

Overweight and Obesity Clinical Trial

Official title:

The Role of Altered Nutrient Partitioning in Food Reward

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05200845
• Other study ID #: 21-964
• Status: Completed
• Phase: N/A
• Start date: February 23, 2022
• Est. completion date: June 1, 2023

Study information

• Verified date: August 2023
• Source: Virginia Polytechnic Institute and State University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Obesity remains a public health epidemic despite substantial advances in treatment strategies and therapies in the last decade. Effective strategies to support maintenance of improved metabolic health and reduced body weight are still needed.

Signals from the gut to the brain are important in regulating metabolism and energy balance and have been linked with food reward and preference in metabolically healthy individuals with normal body mass index. In particular, post-ingestive signaling related to glucose metabolism has been linked with food reward and preference. However, not much is known about how these gut and brain signals interact to influence eating behaviors in states of obesity or altered metabolic health. In addition, evidence in rodent models and human studies indicates obesity is associated with a blunted brain response to foods compared with normal body weight. However, whether altered nutrient utilization, termed metabolic inflexibility, influences the relationship between obesity and food reward has yet to be studied.

The overall objective of this proof-of-concept pilot study is to assess the feasibility of measuring reward response following a flavor-nutrient conditioning paradigm across the normal to obese body mass index (BMI) range and in states of altered metabolic health. The aims of this study are: 1) to determine whether differences in reinforcement learning/flavor-nutrient conditioning of carbohydrate can be measured across the body mass index range; and 2) to determine the feasibility of assessing metabolic flexibility and whether a relationship between metabolic flexibility and calorie-predictive reward can be detected.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 19
• Est. completion date: June 1, 2023
• Est. primary completion date: June 1, 2023
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 45 Years

Eligibility

Inclusion Criteria:

1. BMI between 18.5-40 kg/m2

2. Not pregnant or planning to become pregnant during study participation

3. Residing in the Roanoke area and/or willing/able to attend sessions at the Fralin Biomedical Research Institute

4. Able to speak and write in English

5. Specific to fMRI scan only: BMI between 25-35 kg/m2

Exclusion Criteria:

1. Current inhaled nicotine use

2. History of alcohol dependence.

3. Current or past diagnosis of diabetes or thyroid problems.

4. Glycated hemoglobin (Hemoglobin A1C) >5.7%

5. Taking medications known to influence study measures (including antiglycemic agents, thyroid medications, sleep medications)

6. Active medical or neurologic disorder.

7. Recent change in body weight (gain or loss of > 5 lbs within the past 3 months)

8. Current shift work (typical pattern of work/activity overnight)

9. Previous weight loss surgery

10. Adherence to a special diet within the past 3 months (e.g., low-carb or ketogenic diet, exclusion of food groups/specific macronutrients, intermittent fasting, etc.)

11. Allergy to any food or ingredient included in the study diets, meals, or beverages

12. Currently pregnant or planning to become pregnant during study participation

13. Claustrophobia

14. Contraindications for MRI, including pacemaker, aneurysm clips, neurostimulators, cochlear or other implants, metal in eyes, regular work with steel, etc. (Note: This is an fMRI-specific exclusion criterion. Participants may be allowed to participate in all other study sessions and measures that do not involve fMRI.)

15. Contraindications for bioelectrical impedance analysis, specifically implanted devices

Related Conditions & MeSH terms

• Overweight
• Overweight and Obesity

Intervention

Other:
• Conditioned Stimulus + (CS+): Flavored beverage solution with 75 calories of sucrose
Participants will consume flavored beverage solutions containing 75 calories of sucrose in 6 exposure sessions within 1 week. One exposure session will include pre- and post-consumption blood draws over a 2-hour period, and one exposure session will include indirect calorimetry measurement pre- and post-consumption. The other 4 exposure sessions will occur at specified times outside the laboratory sessions. Subjective ratings of internal state (i.e., hunger, fullness, and thirst) will be collected throughout each exposure. Subjective ratings of liking and wanting of each beverage will also be assessed.
• Conditioned Stimulus - (CS-): Flavored beverage solution with sweetness-matched sucralose
Participants will consume flavored beverage solutions sweetened with sucralose to match the sweetness of 75 calories of sucrose in 6 exposure sessions within 1 week. One exposure session will include pre- and post-consumption blood draws over a 2-hour period, and one exposure session will include indirect calorimetry measurement pre- and post-consumption. The other 4 exposure sessions will occur at specified times outside the laboratory sessions. Subjective ratings of internal state (i.e., hunger, fullness, and thirst) will be collected throughout each exposure. Subjective ratings of liking and wanting of each beverage will also be assessed.
• High-Fat Test Meal Inside a Metabolic Chamber
A high-fat test meal (60% fat, 20% carbohydrate) will be provided after a 1-hour baseline measurement of substrate oxidation during a 6-hour metabolic chamber stay. Postprandial substrate oxidation will be measured for 5 hours.
• High-Carbohydrate Test Meal Inside a Metabolic Chamber
A high-carbohydrate test meal (60% carbohydrate, 20% fat) will be provided after a 1-hour baseline measurement of substrate oxidation during a 6-hour metabolic chamber stay. Postprandial substrate oxidation will be measured for 5 hours.

Locations

Country	Name	City	State
United States	Fralin Biomedical Research Institute at Virginia Tech Carilion	Roanoke	Virginia

Sponsors (1)

Lead Sponsor	Collaborator
Virginia Polytechnic Institute and State University

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change in preference- liking	Subjective ratings of liking of flavors used in the intervention will be assessed at baseline and after the intervention. The generalized Labeled Magnitude Scale will be used. The scale is anchored by descriptors of "Most Disliked Sensation Imaginable" and "Most Liked Sensation Imaginable" at the lower and upper ends, respectively. The score is determined by the place on the scale participants select (range of scale is 0-100). An increase in score from baseline to post-intervention indicates an increase in liking.	15-minute measurement
Secondary	Change in preference- wanting	Subjective ratings of liking of flavors used in the intervention will be assessed at baseline and after the intervention. A Visual Analog Scale will be used. Participants select a place on the line that corresponds with their subjective rating, and the score is determined by the place selected (range of scores is 0-100). The line is anchored by polar opposite descriptors ("Do not want at all" and "Want very much"). An increase in score from baseline to post-intervention indicates and increase in wanting.	15-minute measurement
Secondary	Change in preference- wanting	Ad libitum intake will be used as a measure of wanting in a post-test session. Participants will be provided each beverage used during the intervention and asked to drink as much or as little of them as they would like over a 30-minute period.	30-minute measurement
Secondary	Change in preference- wanting	Forced choice will be used as a measure of wanting in a post-test session. Participants will be provided each of the beverages used during the intervention and asked to choose 1 to take home with them.	5-minute measurement
Secondary	Blood oxygen level-dependent (BOLD) response to beverages	In a post-test session, functional magnetic resonance imaging (fMRI) scans will be performed while beverages (without calories) used during the intervention are delivered through a custom manifold fitted to a head coil and connected to a pump system that allows precisely timed and measured delivery of liquids.	30-minute measurement
Secondary	Substrate oxidation response to test meals	Indirect calorimetry in a metabolic chamber will be used to assess substrate oxidation response to high-fat and high-carbohydrate test meals.	6-hour measurement
Secondary	Blood glucose response to beverages	Blood glucose will be assessed at baseline and at set time points for 2 hours after consumption of intervention beverages in one exposure session.	2-hour measurement
Secondary	Blood insulin response to beverages	Blood insulin will be assessed at baseline and at set time points for 2 hours after consumption of intervention beverages in an exposure session.	2-hour measurement
Secondary	Energy expenditure in response to beverages	Indirect calorimetry will be used to determine energy expenditure at baseline (for 30 minutes) and for 1 hour after consumption of intervention beverages in an exposure session.	1.5-hour measurement
Secondary	Respiratory exchange ratio in response to beverages	Indirect calorimetry will be used to determine respiratory exchange ratio at baseline (for 30 minutes) and for 1 hour after consumption of intervention beverages in an exposure session.	1.5-hour measurement
Secondary	Substrate oxidation in response to beverages	Indirect calorimetry will be used to determine substrate oxidation at baseline (for 30 minutes) and for 1 hour after consumption of intervention beverages in an exposure session.	1.5-hour measurement